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ABSTRACT: Metabolomics profiling and bioinformatics technologies were
used to determine the relationship between exercise-induced increases in IL-
6 and lipid-related metabolites. Twenty-four male runners (age 36.5 ± 1.8 y)
ran on treadmills to exhaustion (2.26 ± 0.01 h, 24.9 ± 1.3 km, 69.7 ± 1.9%
VO2max). Vastus lateralis muscle biopsy and blood samples were collected
before and immediately after running and showed a 33.7 ± 4.2% decrease in
muscle glycogen, 39.0 ± 8.8-, 2.4 ± 0.3-, and 1.4 ± 0.1-fold increases in
plasma IL-6, IL-8, and MCP-1, respectively, and 95.0 ± 18.9 and 158 ±
20.6% increases in cortisol and epinephrine, respectively (all, P < 0.001).
The metabolomics analysis revealed changes in 209 metabolites, especially
long- and medium-chain fatty acids, fatty acid oxidation products
(dicarboxylate and monohydroxy fatty acids, acylcarnitines), and ketone
bodies. OPLS-DA modeling supported a strong separation in pre- and post-
exercise samples (R2Y = 0.964, Q2Y = 0.902). OPLSR analysis failed to
produce a viable model for the relationship between IL-6 and all lipid-related metabolites (R2Y = 0.76, Q2Y = −0.0748).
Multiple structure equation models were evaluated based on IL-6, with the best-fit pathway model showing a linkage of exercise
time to IL-6, then carnitine, and 13-methylmyristic acid (a marker for adipose tissue lipolysis) and sebacate. These metabolomics-
based data indicate that the increase in plasma IL-6 after long endurance running has a minor relationship to increases in lipid-
related metabolites.
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INTRODUCTION
Metabolomics is the study of small molecular weight molecules
(metabolites) present in a biological system and when
combined with bioinformatics can reveal new insights regarding
complex metabolic processes following lifestyle and pharma-
ceutical interventions.1 A nontargeted metabolomics approach
provides a system-wide view of the metabolic response to
exercise by simultaneously measuring and identifying shifts in
hundreds of metabolites. Although the number of studies is
limited, metabolomics-based investigations indicate that
prolonged and intensive exercise is associated with extensive
lipid mobilization and oxidation, marked by increases in
metabolites related to carnitine metabolism and long-chain,
dicarboxylate, and essential fatty acid metabolism.2−7
IL-6 is produced by a wide variety of cell types and has
multiple, context-dependent immuno-modulating and immuno-
metabolic roles.8,9 During exercise, IL-6 serves as a complex
communication factor between skeletal muscle, liver, pancreas,
and other metabolic tissues.9 Muscle- and adipose-derived IL-6
has been identified as a hormone-like signaling agent to adipose
tissue to increase lipolysis and muscle fat oxidation, especially
when muscle glycogen levels become depleted.10−12
In cell culture experiments, IL-6 markedly increases both
lipolysis and free fatty acid (FFA) oxidation, but IL-6
concentration levels typically far exceed the increases in plasma
IL-6 measured after prolonged and intensive exercise
bouts.11,13,14 Infusion of recombinant IL-6 (rIL-6) for several
hours into resting humans increases whole-body lipolysis and
FFA oxidation, but plasma IL-6 levels, as with cell culture
studies, often exceed what is attained post-exercise. Addition-
ally, interpretation of data from rIL-6 infusion studies can be
confounded by concomitant increases in lipolytic hormones
such as cortisol and epinephrine and the absence of the
multitude of other hormones, metabolites, and proteins
generated during intensive exercise.11,15
Exercise-induced increases in plasma IL-6 and lipolysis may
be linked, but this has not yet been tested using metabolomics-
based procedures that allow the simultaneous evaluation of a
high number of metabolites from the lipid super pathway. The
primary purpose of this study was to use metabolomics
profiling and bioinformatics technologies to evaluate the
relationship of exercise-induced increases in plasma IL-6 and
lipid-related metabolites in 24 athletes who ran on treadmills to
exhaustion at high intensity.
MATERIALS AND METHODS
Subjects
Subject recruitment was conducted via direct messaging to
runners and running clubs in the Charlotte, NC, metropolitan
area. Subjects included 24 male runners (ages 22−55 years)
who regularly competed in long-distance road races and were
capable of running at ∼70% on treadmills to exhaustion.
Subjects signed informed consent forms, and study procedures
were approved by the Institutional Review Board at
Appalachian State University (ASU).
Baseline Testing
Two weeks prior to the running trial, subjects were tested for
VO2max during a graded, treadmill test with the Cosmed
Fitmate metabolic system (Cosmed, Rome, Italy). Body
composition was measured with the Bod Pod body
composition analyzer (Life Measurement, Concord, CA).
Demographic and training histories were acquired with
questionnaires.
Running Trial
During the 3-day period prior to the running trial, subjects were
asked to taper their exercise training as if preparing for a long-
distance race and to follow a moderate-carbohydrate dietary
regimen (∼55% kcal as carbohydrates) by choosing foods from
a list provided by the investigative team (to ensure a similar fat
and carbohydrate intake before the run to exhaustion). A
standardized meal consisting of Boost Plus (Neśtle Nutrition,
Slorham Park, NJ) was ingested at 12:00 pm, with energy
intake adjusted to 5 kcal/kg body weight. Boost Plus is a
nutritionally complete, high-energy oral supplement with an
energy density of 6.4 kJ/mL (1.52 kcal/mL) and 15% of energy
as protein, 35% as fat, and 50% as carbohydrate and 24 vitamins
and minerals. Subjects reported to the lab at 2:15 pm and
provided blood and muscle biopsy samples. At 3:00 pm,
subjects ran on laboratory treadmills with the speed set at 70%
of VO2max and drank water ad libitum, without ingestion of any
other beverages or food. Subjects ran as long as possible until
exhaustion, defined as the inability of the subject to continue
running at 70% VO2max despite verbal urging from the
laboratory staff. Metabolic measures from the Cosmed Fitmate
metabolic system and the rating of perceived exertion (RPE)
were taken at 15 min, then every 60 min during the running
bout to verify that the appropriate intensity was maintained.
Blood and muscle samples were taken again immediately
following exercise.
Cytokine Analysis
Total plasma concentrations of three cytokines [monocyte
chemoattractant protein-1 (MCP-1), IL-6, and IL-8] were
determined using an electrochemiluminescence-based solid-
phase sandwich immunoassay (Meso Scale Discovery,
Gaithersburg, MD). All samples and provided standards were
analyzed in duplicate, and the intra-assay CV ranged from 1.7
to 7.5% and the interassay CV ranged from 2.4 to 9.6% for all
cytokines measured. Pre- and post-exercise samples for the
cytokines were analyzed on the same assay plate to decrease
interkit assay variability.
Stress Hormone Analysis
Serum cortisol was measured with an electrochemilumines-
cence immunoassay (ECLIA) and plasma epinephrine with
high-pressure liquid chromatography (HPLC) and electro-
chemical (EC) detection through a commercial lab (LabCorp,
Burlington, NC).
Muscle Biopsy Procedures and Glycogen Analysis
Pre- and post-exercise muscle biopsy samples were acquired
from the vastus lateralis on the same leg approximately 2 cm
apart using procedures previously described.16 Local anesthesia
(1% xylocaine, Hospira, Lake Forest, IL) was injected
subcutaneously. After a small incision, a muscle biopsy sample
was obtained using the suction-modified percutaneous needle
biopsy procedure.16 Muscle was trimmed of connective tissue
and fat and immediately frozen in liquid nitrogen. Samples were
stored at −80 °C until subsequent analysis (within 3 months of
study completion). A glycogen assay kit (Catalog no. MAK016,
Sigma-Aldrich, St. Louis, MO) was used to determine the
concentration of glycogen in vastus lateralis muscle homoge-
nates. In this coupled enzyme assay, glucoamylase hydrolyzed
glycogen to glucose; then. the glucose was oxidized to yield a
product that reacted with a probe to generate a color detectable
with a microplate reader (Synergy H1 Hybrid Reader, BioTek
Instruments, Winooski, VT) at 570 nm.
Metabolomics
The nontargeted metabolic profiling instrumentation employed
for this analysis combined three independent platforms:
ultrahigh performance liquid chromatography−tandem mass
spectrometry (UHPLC−MS/MS) optimized for basic species,
UHPLC−MS/MS optimized for acidic species, and gas
chromatography−mass spectrometry (GC−MS).17,18 Blood
samples were collected in ethylenediaminetetraacetic acid
(EDTA) tubes and centrifuged at 3000 rpm for 10 min at 4
°C, with the plasma aliquoted, snap frozen in liquid nitrogen,
and then stored at −80 °C until analysis (within 3 months of
study completion). For each plasma sample, 100 μL was used
for analyses. Using an automated liquid handler (Hamilton
LabStar, Salt Lake City, UT), protein was precipitated from the
plasma with methanol that contained four standards to report
on extraction efficiency. The resulting supernatant was split into
equal aliquots for analysis on the three platforms. Aliquots,
dried under nitrogen and vacuum-desiccated, were subse-
quently reconstituted in either 50 μL of 0.1% formic acid in
water (acidic conditions) or 50 μL of 6.5 mM ammonium
bicarbonate in water, pH 8 (basic conditions) for the two
UHPLC−MS/MS analyses or derivatized to a final volume of
50 μL for GC−MS analysis using equal parts bistrimethylsilyl-
trifluoroacetamide and solvent mixture acetonitrile/dichloro-
methane/cyclohexane (5:4:1) with 5% triethylamine at 60 °C
for 1 h. In addition, three types of controls were analyzed in
concert with the experimental samples: aliquots of a well-
characterized human plasma pool served as technical replicates
throughout the data set, extracted water samples served as
process blanks, and a cocktail of standards spiked into every
analyzed sample allowed instrument performance monitoring.
Standards to monitor extraction were d6-cholesterol, fluoro-
phenylglycine, and tridecanoic acid. A standard to monitor
GC−MS derivatization was 2-tert-butyl-6-methylphenol
(BHT). GC−MS standards to monitor GC and MS perform-
ance were C5−C18 alkylbenzenes. Pre- and post-exercise
samples were randomized across platform run days.
For UHLC−MS/MS analysis, aliquots were separated using
a Waters Acquity UPLC (Waters, Millford, MA) instrument
with separate acid/base-dedicated 2.1 mm × 100 mm Waters
BEH C18 1.7 μm particle columns heated to 40 °C and
analyzed using an LTQ mass spectrometer (Thermo Fisher
Scientific, Waltham, MA) that consisted of an electrospray
ionization (ESI) source and linear ion-trap (LIT) mass
analyzer.17 Extracts reconstituted in formic acid were gradient
eluted at 350 μL/min using (A) 0.1% formic acid in water and
(B) 0.1% formic acid in methanol (0% B to 70% B in 4 min,
70−98% B in 0.5 min, 98% B for 0.9 min), whereas extracts
reconstituted in ammonium bicarbonate used (A) 6.5 mM
ammonium bicarbonate in water, pH 8, and (B) 6.5 mM
ammonium bicarbonate in 95/5 methanol/water (same
gradient profile as above) at 350 μL/min. The MS instrument
scanned 99−1000 m/z and alternated between MS and MS2
scans using dynamic exclusion with approximately six scans per
second. Derivatized samples for GC−MS were separated on a
5% diphenyl/95% dimethyl polysiloxane-fused silica column
with helium as the carrier gas and a temperature ramp from 60
to 340 °C and then analyzed on a Thermo-Finnigan Trace
DSQ MS (Thermo Fisher Scientific) operated at unit mass
resolving power with electron impact ionization and a 50−750
atomic mass unit scan range. Metabolites were identified by
automated comparison of the ion features in the experimental
samples to a reference library of chemical standard entries that
included retention time, molecular weight (m/z), preferred
adducts, and in-source fragments as well as associated MS
spectra and were curated by visual inspection for quality control
using software developed at Metabolon (Durham, NC).18
Common and biologically abundant isomers of unsaturated
fatty acids containing the n3, n6, and n9 configuration are
contained in Metabolon’s chemical standard library. LC−MS
standards to monitor LC and MS performance were d3-leucine,
chloro- and bromo-phenylalanine, d2-maleic acid, amitriptyline,
and d10-benzophenone. Biochemical identifications were based
on three criteria: retention index within a narrow window of the
proposed identification, match to the library within 0.4 m/z,
and the MS/MS forward and reverse scores between the
experimental data and authentic standards. The MS/MS scores
were based on a comparison of the ions present in the
experimental spectrum to the ions present in the library
spectrum.
Statistical Analysis
Data are expressed as mean ± SE. Cytokine, stress hormone,
and muscle glycogen data were analyzed for pre-to-post
exercise changes using paired t tests. For the metabolomics
statistical analyses, any missing values were assumed to be
below the limits of detection, and these values were imputed
with the compound minimum (minimum value imputation).
Each metabolite was median-scaled. Paired t-test analysis on
log-transformed median-scaled metabolomics data was per-
formed to identify metabolites that were significantly different
between pre- and post-exercise samples. An estimate of the
Benjamini-Hochberg false discovery rate (FDR) was calculated
to take into account the multiple comparisons that normally
occur in metabolomics-based studies, with FDR < 0.05 used as
the cutoff for significance. Pre-to-post exercise fold changes
were calculated using median-scaled intensity values. Metabo-
lites with FDR < 0.05 and fold change >10% were considered
as exercise responding metabolites. The correlations between
the fold changes of exercise responding metabolites and the
fold changes of plasma IL-6, serum cortisol, and plasma
epinephrine were determined by Pearson correlation coefficient
analysis. Orthogonal partial least-squares discriminant analysis
(OPLS-DA) was also used to identify metabolites that
distinguished post-exercise and pre-exercise samples. Variable
influence on projection (VIP) scores greater than 1.75 were
used as the cutoff to select the most important metabolites
responding to exercise. Exercise responding metabolites from
the lipid super pathway identified by paired t tests (P < 0.05
and fold change >10%) were further analyzed by orthogonal
partial least-squares regression (OPLSR) in SIMCA (Version
14, MKS Data Analytics Solutions, Umea,̊ Sweden), which
identified lipid-related metabolites whose changes were most
associated with the change of plasma IL6, serum cortisol,
plasma epinephrine, and muscle glycogen depletion. Two
validation methods, including a 7-round cross validation and a
permutation-based validation, were used to prevent overfitting.
An OPLS model was considered valid if its prediction ability
was better than 95% of the models built using the 999
permuted data sets. Structure equation models were used to
evaluate potential pathways that explained the relationship
between time to exhaustion and metabolic responses. The
validity of each model was determined by several fit indices,
including model chi-square, root-mean-square error of
approximation (RMSEA), goodness of fit index (GFI),
Bentler-Bonett normed-fit index (NFI), and Bentler compara-
tive fit index (CFI).19−22 Other than OPLS analysis using
SIMCA, all other analyses were performed using SAS (SAS
institute, Cary, NC)
RESULTS
Study participants included 24 trained male runners (ages 22 to
55 years). Table 1 summarizes demographic and performance
data for these male endurance athletes. The runners were able
Table 1. Subject Characteristics and Run-to-Exhaustion
Performance Measures (N = 24)a
variable mean ± SE
age (years) 36.5 ± 1.8
height (m) 1.78 ± 0.01
weight (kg) 77.3 ± 1.9
body fat (%) 15.0 ± 1.0
VO2max (mL kg
−1 min−1) 60.0 ± 1.5
HRmax (beats/min) 185 ± 2.3
Run Trial Performance
time to exhaustion (h) 2.26 ± 0.01
distance (km) 24.9 ± 1.3
VO2 (mL·kg
−1 min−1) 41.5 ± 1.0
VO2 (%VO2max) 69.7 ± 1.9
HR (beats/min) 157 ± 2.4
%HRmax 85.1 ± 0.9
ventilation (L/min) 77.6 ± 1.9
RPE
average 13.7 ± 0.2
ending 17.7 ± 0.2
aVO2, volume of oxygen consumed; HR, heart rate; RPE, rating of
perceived exertion.
to maintain an average intensity of 69.7 ± 1.9% VO2max for 2.26
± 0.01 h and 24.9 ± 1.3 km until exhausted, with an ending
RPE of 17.7 ± 0.2. Age had no influence on run time to
exhaustion in these athletes (r = −0.119, P = 0.580).
Pre- and postrun plasma cytokine, stress hormone, and
muscle glycogen data are summarized in Table 2. Plasma IL-6,
IL-8, and MCP-1 increased 39.0 ± 8.8-, 2.4 ± 0.3-, and 1.4 ±
0.1-fold, respectively (all, P < 0.001). Serum cortisol and plasma
epinephrine increased 95.0 ± 18.9 and 158 ± 20.6% post-
exercise, respectively. Skeletal muscle glycogen sampled from
the vastus lateralis decreased 33.7 ± 4.2% (P < 0.001).
The metabolomics analysis revealed 380 detectable com-
pounds of known identity with paired t tests indicating post-
exercise increases and decreases for 166 and 43 metabolites,
respectively (FDR < 0.05 and fold change >10%). OPLS-DA
modeling supported a strong separation in post-exercise
(green) and pre-exercise (blue) samples (R2Y = 0.964 and
Q2Y = 0.902) (Figure 1). The predictive ability of the model
was found to be better than any models generated from the 999
permutated data sets and therefore passed permutation-based
validation. Table 3 lists 45 metabolites with VIP scores of 1.75
and higher and fold changes of 2.0 and higher (FDR < 0.01).
All but 3 of these 45 metabolites were in the lipid super
pathway, with a predominance of post-exercise increases in
plasma long- and medium-chain fatty acids, fatty acid oxidation
products (dicarboxylate and monohydroxy fatty acids,
acylcarnitines), and ketone bodies. Supplemental Table S1
contains the full list of metabolites detected, with ranking by
VIP score.
Pearson correlation coefficients for relationships between
pre-to-post exercise increases in plasma IL-6, cortisol, and
epinephrine and changes in plasma metabolites from the lipid
super pathway and other outcome measures (Table 2) are
summarized in Table 4. The post-exercise increase in plasma
IL-6 was most closely linked to exercise time to exhaustion,
increases in IL-8 and MCP-1, the androgen hormone
metabolite pregnen-diol disulfate, carnitine, and sebacate. The
post-exercise increase in cortisol was related to exercise time to
exhaustion and increases in 11 lipid-related metabolites
including seven metabolites involved with lipid mobilization
and oxidation. The increase in epinephrine was related to
increases in three metabolites from the lipid super pathway,
including two involved with bile acid metabolism.
OPLSR analysis was used to evaluate the relationship
between exercise-induced changes in plasma IL-6 and all
lipid-related metabolites listed in Supplemental Table S1
(minus any metabolite not from the lipid super pathway). No
viable model was produced from this analysis (R2Y = 0.76,
Q2Y = −0.0748). OPLSR analysis did reveal a relationship
between changes in serum cortisol and all lipid-related
metabolites (R2Y = 1, Q2Y = 0.434). Permutation-based
validation found the predictive ability of this model was better
than 94.1% of models generated from the permutated data sets
(P = 0.059). (See Figure S1 for the scatter loading plot.) Similar
OPLSR analyses for changes in plasma epinephrine and muscle
glycogen with lipid-related metabolites failed to produce viable
models.
Multiple structure equation models were evaluated to depict
potential pathways that explained the relationship between
exercise time to exhaustion, changes in plasma IL-6, and lipid
metabolism. Of the various models evaluated, Figure 2 had the
strongest fit when tested with five different model fit indices [P
value (Chi-Square) = 0.8360 (P ranges between 0 and 1, with P
> 0.05 indicating a good fit);19 GFI = 0.9515 (GFI ranges
between 0 and 1, with value >0.95 indicating a good fit);20
Bentler-Bonett NFI = 0.9433 (NFI ranges between 0 and 1,
with value >0.90 indicating a good fit);21 RMSEA = 0 (RMSEA
< 0.06 indicates a good fit);22 and Bentler CFI = 1 (CFI ranges
between 0 and 1, with value >0.95 indicating a good fit).21 This
model suggests that increased running time to exhaustion is
linked to higher levels of plasma IL-6 that are then linked
through carnitine to 13-methylmyristic acid (a marker of lipid
metabolism) and sebacate (a dicarboxylic fatty acid).
DISCUSSION
This metabolomics-based analysis showed that the substantial
increase in lipid metabolites in 24 male athletes after prolonged
and intensive running was related more to changes in serum
cortisol than increases in plasma IL-6, epinephrine, or muscle
glycogen depletion. This finding was strengthened through use
of bioinformatics procedures involving OPLSR analyses. A
structure equation model supported one potential pathway for
the relationship between run time to exhaustion and increases
in plasma IL-6, carnitine, and two lipid-related metabolites (13-
methylmyristic acid and sebacate).
As in previous global metabolomics-based laboratory studies
using a prolonged exercise stress design, plasma IL-6 increased
∼39-fold, and post-exercise metabolite shifts were predom-
inately from the lipid super pathway.2−4 Endurance running
Table 2. Run-to-Exhaustion Effects on Plasma Cytokines,
Stress Hormones, and Muscle Glycogen in N = 24 Runnersa
variable pre-exercise post-exercise
plasma IL-6 (pg/mL) 0.61 ± 0.08 16.4 ± 2.0b
plasma IL-8 (pg/mL) 4.23 ± 0.29 13.8 ± 1.1b
plasma MCP-1 (pg/mL) 105 ± 3.5 253 ± 14.0b
serum cortisol (pg/mL) 10.1 ± 0.6 18.4 ± 1.4b
plasma epinephrine (pg/mL) 66.0 ± 5.6 159 ± 15.2b
muscle glycogen (mmol/kg) 70.6 ± 3.4 47.0 ± 3.7b
aIL = interleukin; MCP-1 = monocyte chemoattractant protein-1. bP
< 0.001 versus pre-exercise.
Figure 1. Post-exercise (green) and pre-exercise (blue) samples were
well-separated in this OPLS-DA model (R2Y = 0.964 and Q2Y =
0.902 indicate very good model fitting and predictability). This model
passed permutation-based validation, and the predictability of this
model was found to be better than models built using any of the 999
permutated data sets. The metabolites that contributed the most to the
separation are shown in Table 3.
was associated with substantial increases in long- and medium-
chain fatty acids, fatty acid oxidation products, acylcarnitines,
and ketone bodies. During prolonged and intensive exercise,
IL-6 is produced by multiple cell types both within and outside
muscle and adipose tissue, serving as a hormone-like signaling
agent between metabolically active tissues. Cell culture, rodent-
based, and recombinant IL-6 infusion studies indicate that one
function for this pleiotropic cytokine is to increase lipolysis and
FFA oxidation.8−15,23 However, direct application of these data
to what occurs in vivo during prolonged exercise bouts is
problematic for several reasons. The IL-6 concentration levels
used in vitro and attained during recombinant IL-6 infusion
studies are substantially higher than what is typically measured
in laboratory-based human exercise trials.11,13−15 Increases in
cortisol and other lipolytic hormones often accompany elevated
IL-6 following rIL-6 infusion in resting adults,11,15 but plasma
glycerol and fatty acid levels are well below what is attained
post-exercise in endurance athletes. Sympathetic nervous
system (SNS) stimulation is a major inducer of adipose tissue
lipolysis during exercise and may account for these disparities.24
Table 3. Rank Order of Metabolites (N = 45) with VIP Scores >1.75 and Fold Changes >2.0 in N = 24 Runners Following a
Treadmill Run to Exhaustion at 70% VO2max
a
biochemical super pathway sub pathway VIP score fold change
glycerol lipid glycerolipid metabolism 2.15 7.59
myristate (14:0) lipid long-chain fatty acid 2.13 10.3
oleate (18:1n9) lipid long-chain fatty acid 2.12 7.61
margarate (17:0) lipid long-chain fatty acid 2.10 5.47
16-hydroxypalmitate lipid fatty acid, monohydroxy 2.09 4.83
10-heptadecenoate (17:1n7) lipid long-chain fatty acid 2.09 11.6
myristoleate (14:1n5) lipid long-chain fatty acid 2.09 13.3
palmitoleate (16:1n7) lipid long-chain fatty acid 2.08 15.3
palmitate (16:0) lipid long-chain fatty acid 2.08 3.62
dihomolinoleate (20:2n6) lipid long-chain fatty acid 2.08 6.78
eicosenoate (20:1n9 or 1n11) lipid long-chain fatty acid 2.07 8.23
laurate (12:0) lipid medium-chain fatty acid 2.07 8.47
10-nonadecenoate (19:1n9) lipid long-chain fatty acid 2.07 8.58
linoleate (18:2n6) lipid essential fatty acid 2.06 4.30
linolenate (18:3n3 or 3n6) lipid essential fatty acid 2.06 7.26
hexadecanedioate (C16) lipid fatty acid, dicarboxylate 2.06 10.2
stearate (18:0) lipid long-chain fatty acid 2.06 2.71
docosadienoate (22:2n6) lipid long-chain fatty acid 2.05 5.74
nonadecanoate (19:0) lipid long-chain fatty acid 2.02 3.43
5-dodecenoate (12:1n7) lipid medium-chain fatty acid 2.00 10.2
stearidonate (18:4n3) lipid long-chain fatty acid 1.99 11.8
arachidate (20:0) lipid long-chain fatty acid 1.98 3.01
pentadecanoate (15:0) lipid long-chain fatty acid 1.98 4.46
3-hydroxybutyrate (BHBA) lipid ketone bodies 1.97 7.24
caprate (10:0) lipid medium-chain fatty acid 1.97 3.51
decanoylcarnitine (C10) lipid carnitine metabolism 1.96 7.12
methionylalanine peptide dipeptide 1.95 4.70
tetradecanedioate (C14) lipid fatty acid, dicarboxylate 1.93 5.45
succinate energy krebs cycle 1.92 2.90
octanoylcarnitine (C8) lipid carnitine metabolism 1.92 6.78
acetoacetate lipid ketone bodies 1.92 5.13
3-hydroxydecanoate lipid fatty acid, monohydroxy 1.92 5.07
docosapentaenoate (DPA; 22:5n3) lipid essential fatty acid 1.89 3.63
13-HODE + 9-HODE lipid fatty acid, monohydroxy 1.89 4.33
17-methylstearate lipid fatty acid, branched 1.88 3.69
laurylcarnitine (C12) lipid carnitine metabolism 1.88 15.0
cis-4-decenoyl carnitine lipid carnitine metabolism 1.85 6.45
adrenate (22:4n6) lipid long-chain fatty acid 1.85 2.25
octadecanedioate (C18) lipid fatty acid, dicarboxylate 1.82 3.24
erucate (22:1n9) lipid long-chain fatty acid 1.77 3.86
10-undecenoate (11:1n1) lipid medium-chain fatty acid 1.77 3.53
methylpalmitate (15 or 2) lipid fatty acid, branched 1.76 4.34
3-hydroxyoctanoate lipid fatty acid, monohydroxy 1.75 3.41
malate energy Krebs cycle 1.75 2.34
dodecanedioate (C12) lipid fatty acid, dicarboxylate 1.75 3.83
aVIP scores were generated by OPLS-DA between pre- and post-exercise samples (Figure 1). Pre-to-post exercise fold changes were calculated using
median scaled intensity values. These metabolites were also found to have FDR < 0.01 by paired t-test analysis between pre- and post-exercise
samples.
In our exercise-based study, plasma IL-6 increased to only 16
pg/mL but was accompanied by a 7.59-fold increase in plasma
glycerol and 2- to 15-fold increases in a wide variety of lipid-
related metabolites. In contrast, van Hall et al.15 infused rIL-6
(or saline) for 3 h into healthy males at two doses resulting in
plasma IL-6 levels of 140 and 320 pg/mL with arterial cortisol
concentrations three times higher than saline controls and
glycerol levels that never rose higher than 50% above controls.
In another study using a more modest dose, eight healthy males
were infused with rIL-6 for 4 h, with plasma IL-6 levels rising to
40 pg/mL.23 Fatty acid oxidation increased modestly in muscle
but not adipose tissue, and blood levels of palmitate increased
<50%, far below the 3.62-fold increase measured in the current
study.
The use of a systems biology approach such as metabolomics
combined with cytokine, stress hormone, and muscle glycogen
measurements provides a more global, in vivo, comprehensive
understanding of the linkage between IL-6, lipolysis, and fat
oxidation within an exercise context. OPLSR analysis was
unable to produce a viable model when evaluating the
relationship between exercise-induced changes in plasma IL-6
and all lipid-related metabolites listed in Supplement Table S1.
The modest post-exercise increase in plasma IL-6 was most
closely linked to exercise time to exhaustion and increases in
IL-8 and MCP-1. We have previously reported that variance in
plasma IL-6 increases in male cyclists in response to 2 h of
endurance exercise was best explained by the level of self-
selected exercise intensity.25 The increase in IL-6 post-exercise
in the current study was correlated to carnitine and sebacate,
and our pathway model suggests that IL-6 may be linked to
sebacate (a 10-carbon aliphatic dicarboxylic acid) and 13-
methylmyristic (i.e., 13-methyltetradecanoic acid or 13-MTD)
acid through carnitine. The branched fatty acid 13-MTD seems
likely to be derived from the consumption of animal fats before
becoming incorporated into complex lipids (including
triglycerides). During lipolysis, 13-MTD can be used as a
marker of mobility of fatty acyl chains in adipose tissue.26
Sebacate is a probable product of omega-oxidation of fatty
acids, and this water-soluble lipid substrate does not require
hydrolysis and is immediately available for cellular utilization.27
Limited data suggest that IL-6 may enhance long-chain fatty
acid update into muscle.28 In cultured primary human
trophoblast cells, IL-6 but not TNF-alpha, promotes fatty
acid accumulation.29
Taken together, the metabolomics-based data from the
current study with 24 male runners do not support a strong
relationship between the modest increase in IL-6 and the strong
increase in numerous lipid-related metabolites following
prolonged and intensive running. This finding is consistent
with the finding that IL-6 had no effect on adipose tissue
lipolysis in IL-6-deficient mice that exercised for 90 min.30 In
that study, IL-6 was involved in regulating the induction of
glyceroneogenic enzymes that re-esterify fatty acids back into
triglycerides in fat cells. The viewpoint that muscle-derived IL-6
stimulates adipose tissue lipolysis during exercise has not been
consistently supported, as underscored by the data from the
current study and others.8,23,30
Table 4. Pearson Correlation Coefficients for Pre-to-Post-Exercise Increases in IL-6, Cortisol, and Epinephrine with Changes in
Plasma Metabolites from the Lipid Super Pathway and All Outcomes Listed in Table 2 and Exercise Time to Exhaustiona
variable exercise fold change lipid metabolite sub pathway R P value
IL-6 Correlations
IL-8 2.40 0.756 <0.001
exercise time to exhaustion 0.739 <0.001
MCP-1 1.41 0.635 0.001
pregnen-diol disulfate 1.14 sterol/steroid 0.533 0.007
carnitine 1.14 carnitine metabolism 0.493 0.014
sebacate (decanedioate) 3.33 fatty acid, dicarboxylate 0.424 0.039
Cortisol Correlations
pregnenolone sulfate 1.68 sterol/steroid 0.648 0.001
pregn steroid monosulfate 1.33 sterol/steroid 0.622 0.001
taurocholenate sulfate 1.83 bile acid metabolism 0.563 0.004
linolenate (18:3n3 or 3n6) 7.26 essential fatty acid 0.527 0.008
3-hydroxydecanoate 5.07 fatty acid, monohydroxy 0.454 0.026
myristoleate (14:1n5) 13.3 long-chain fatty acid 0.450 0.028
glycocholenate sulfate 1.38 bile acid metabolism 0.450 0.028
13-methylmyristic acid 1.78 fatty acid, branched 0.442 0.030
eicosapentaenoate (EPA; 20:5n3) 2.38 essential fatty acid 0.426 0.038
1-stearoylglycerol (18:0) 1.64 monoacylglycerol 0.416 0.043
exercise time to exhaustion 0.414 0.044
10-undecenoate (11:1n1) 3.53 medium-chain fatty acid 0.406 0.049
Epinephrine Correlations
glycodeoxycholate (−) 0.30 bile acid metabolism −0.558 0.005
glycocholenate sulfate 1.38 bile acid metabolism 0.525 0.008
pregnenolone sulfate 1.68 sterol/steroid 0.481 0.017
aOnly significant correlations are shown.
Figure 2. Best-fit pathway model for variables listed in Table 4.
Numbers represent the standardized effect (beta weight) of the factor
on the left to the one on the right. Time refers to time to exhaustion in
24 male runners who ran on treadmills at ∼70% VO2max. This analysis
was performed using the structural equation model.
OPLSR analysis did reveal a relationship between changes in
serum cortisol and all lipid-related metabolites, confirming the
well-established role of cortisol as a lipolytic hormone.31 No
viable models were produced with OPLSR analysis, however,
for increases in epinephrine or muscle glycogen depletion and
increases in lipid-related metabolites. Epinephrine is a regulator
of intramuscular lipolysis, especially in oxidative muscle.13 In
one study, epinephrine infusion in healthy men increased
plasma epinephrine levels to 221 pg/mL (39% above levels in
the current study) and was associated with a ∼70% increase in
plasma glycerol levels (an index of lipolysis), far below the 7.59-
fold increase measured in the current study.32 rIL-6 infusion for
3 h in 12 healthy males increased plasma IL-6 to 152 pg/mL
and was associated with a strong increase in plasma cortisol but
no change in plasma epinephrine.33 Epinephrine does have a
role in glucoregulation, especially during intense exercise.34 In
the current study, change in plasma epinephrine was most
strongly correlated with change in plasma pyruvate (R = 0.633,
P = 0.001), with a modest relationship to increase in lactate (R
= 0.487, P = 0.016) (data not shown). Norepinephrine was not
measured in the current study, but adipose tissue displays a
high sensitivity to this hormone, leading to high lipolysis
rates.35
CONCLUSIONS
This is the first study to test the relationship between exercise-
induced increases in plasma IL-6 and a high number of lipid-
related metabolites using metabolomics-based procedures.
These data indicate that the increase in plasma IL-6 after
long endurance running has at best a minor relationship to
increases in lipid-related metabolites. This study did not include
the acquisition of a series of exercise-recovery blood samples,
but this approach may not produce useful data due to the
substantial decrease in plasma IL-6 and lipid metabolite
concentrations during the first 1.5 h following vigorous
exercise.4 The measurement of other metabolic hormones
such as glucagon and insulin may have added additional insights
regarding the IL-6 and lipolysis relationship. The pathway
model suggests some involvement of IL-6 with two lipid-related
metabolites through carnitine, an amino acid derivative that
transports long-chain acyl groups into the mitochondrial matrix
for β-oxidation to acetyl-CoA. No prior publications have
shown this linkage between post-exercise increases in plasma
IL-6 and carnitine, and additional research is needed to
investigate this relationship. Although many potential combi-
nations for the pathway model were tested using the outcome
measures summarized in Tables 1−3, we cannot rule out that
IL-6 may operate by activating other intermediate factors.
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interleukin-6 in human splanchnic and adipose tissue. J. Physiol. 2002,
543, 379−386.
(13) Macdonald, T. L.; Wan, Z.; Frendo-Cumbo, S.; Dyck, D. J.;
Wright, D. C. IL-6 and epinephrine have divergent fiber type effects on
intramuscular lipolysis. J. Appl. Physiol. 2013, 115, 1457−1463.
(14) Mattacks, C. A.; Pond, C. M. Interactions of noradrenalin and
tumour necrosis factor alpha, interleukin 4 and interleukin 6 in the
control of lipolysis from adipocytes around lymph nodes. Cytokine+
1999, 11, 334−346.
(15) van Hall, G.; Steensberg, A.; Sacchetti, M.; Fischer, C.; Keller,
C.; Schjerling, P.; Hiscock, N.; Møller, K.; Saltin, B.; Febbraio, M. A.;
Pedersen, B. K. Interleukin-6 stimulates lipolysis and fat oxidation in
humans. J. Clin. Endocrinol. Metab. 2003, 88, 3005−3010.
(16) Shanely, R. A.; Zwetsloot, K. A.; Triplett, N. T.; Meaney, M. P.;
Farris, G. E.; Nieman, D. C. Human skeletal muscle biopsy procedures
using the modified Bergström technique. J. Visualized Exp. 2014, 10,
51812.
(17) Evans, A. M.; DeHaven, C. D.; Barrett, T.; Mitchell, M.;
Milgram, E. Integrated, nontargeted ultrahigh performance liquid
chromatography/electrospray ionization tandem mass spectrometry
platform for the identification and relative quantification of the small-
molecule complement of biological systems. Anal. Chem. 2009, 81,
6656−6667.
(18) DeHaven, C. D.; Evans, A. M.; Dai, H.; Lawton, K. A.
Organization of GC/MS and LC/MS metabolomics data into
chemical libraries. J. Cheminf. 2010, 2, 9.
(19) Barrett, P. Structural equation modelling: Adjudging model fit.
Pers. Individ. Dif. 2007, 42, 815−824.
(20) Miles, J.; Shevlin, M. Effects of sample size, model specification
and factor loadings on the GFI in confirmatory factor analysis. Pers.
Individ. Dif. 1998, 25, 85−90.
(21) Bentler, P. M.; Bonett, D. C. Significance tests and goodness of
fit in the analysis of covariance structures. Psychol. Bull. 1980, 88, 588−
606.
(22) Hu, L. T.; Bentler, P. M. Cutoff criteria for fit indexes in
covariance structure analysis: conventional criteria versus new
alternatives. Struct. Equat. Model. 1999, 6, 1−55.
(23) Wolsk, E.; Mygind, H.; Grøndahl, T. S.; Pedersen, B. K.; van
Hall, G. IL-6 selectively stimulates fat metabolism in human skeletal
muscle. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E832−E840.
(24) McMurray, R. G.; Hackney, A. C. Interactions of metabolic
hormones, adipose tissue and exercise. Sports Med. 2005, 35, 393−412.
(25) Nieman, D. C.; Konrad, M.; Henson, D. A.; Kennerly, K.;
Shanely, R. A.; Wallner-Liebmann, S. J. Variance in the acute
inflammatory response to prolonged cycling is linked to exercise
intensity. J. Interferon Cytokine Res. 2012, 32, 12−17.
(26) Klein, R. A.; Halliday, D.; Pittet, P. G. The use of 13-
methyltetradecanoic acid as an indicator of adipose tissue turnover.
Lipids 1980, 15, 572−579.
(27) Raguso, C. A.; Mingrone, G.; Greco, A. V.; Tataranni, P. A.; De
Gaetano, A.; Castagneto, M. Dicarboxylic acids and glucose utilization
in humans: effect of sebacate. JPEN, J. Parenter. Enteral Nutr. 1994, 18,
9−13.
(28) Chabowski, A.; Zmijewska, M.; Gorski, J.; Bonen, A.; Kaminski,
K.; Kozuch, M.; Winnicka, M. M. IL-6 deficiency increases fatty acid
transporters and intramuscular lipid content in red but not white
skeletal muscle. J. Physiol. Pharmacol. 2008, 59 (Suppl 7), 105−117.
(29) Lager, S.; Jansson, N.; Olsson, A. L.; Wennergren, M.; Jansson,
T.; Powell, T. L. Effect of IL-6 and TNF-α on fatty acid uptake in
cultured human primary trophoblast cells. Placenta 2011, 32, 121−
127.
(30) Wan, Z.; Ritchie, I.; Beaudoin, M. S.; Castellani, L.; Chan, C. B.;
Wright, D. C. IL-6 indirectly modulates the induction of
glyceroneogenic enzymes in adipose tissue during exercise. PLoS
One 2012, 7 (7), e41719.
(31) Van Hall, G. The physiological regulation of skeletal muscle
fatty acid supply and oxidation during moderate-intensity exercise.
Sports Med. 2015, 45 (Suppl1), S23−S32.
(32) Schmidt, S. L.; Bessesen, D. H.; Stotz, S.; Peelor, F. F.; Miller, B.
F.; Horton, T. J. Adrenergic control of lipolysis in women compared
with men. J. Appl. Physiol. 2014, 117, 1008−1019.
(33) Steensberg, A.; Toft, A. D.; Schjerling, P.; Halkjaer-Kristensen,
J.; Pedersen, B. K. Plasma interleukin-6 during strenuous exercise: role
of epinephrine. Am. J. Physiol. Cell Physiol. 2001, 281, C1001−C1004.
(34) Kreisman, S. H.; Ah Mew, N.; Arsenault, M.; Nessim, S. J.;
Halter, J. B.; Vranic, M.; Marliss, E. B. Epinephrine infusion during
moderate intensity exercise increases glucose production and uptake.
Am. J. Physiol. Endocrinol. Metab. 2000, 278, E949−E957.
(35) Quisth, V.; Enoksson, S.; Blaak, E.; Hagström-Toft, E.; Arner,
P.; Bolinder, J. Major differences in noradrenaline action on lipolysis
and blood flow rates in skeletal muscle and adipose tissue in vivo.
Diabetologia 2005, 48, 946−953.
